Evidence map›Paper›PMID 33918397›Full record

ArticleCancers2021

Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic Potpourri.

Alvin Wong, Balamurugan Vellayappan, Lenith Cheng, Joseph J Zhao, Vaishnavi Muthu, Yugarajah Asokumaran, Jia-Li Low, Matilda Lee, Yi-Qing Huang, Nesaretnam Barr Kumarakulasinghe and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Alvin WongDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.ORCID 0000-0002-2020-9624
Balamurugan VellayappanDepartment of Radiation Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Lenith ChengDepartment of Diagnostic Imaging, National University Hospital, Singapore 119228, Singapore.ORCID 0000-0003-2666-4748
Joseph J ZhaoYong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Vaishnavi MuthuDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Yugarajah AsokumaranDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Jia-Li LowDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Matilda LeeDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Yi-Qing HuangDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Nesaretnam Barr KumarakulasingheDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Natalie NgoiDepartment of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore.
Cheng-Nang LeongDepartment of Radiation Oncology, National University Cancer Institute, Singapore 119228, Singapore.ORCID 0000-0003-2366-0848
Wynne ChuaDepartment of Diagnostic Imaging, National University Hospital, Singapore 119228, Singapore.
Yee-Liang ThianDepartment of Diagnostic Imaging, National University Hospital, Singapore 119228, Singapore.
National University Cancer Institute, Singapore · SGNational University Hospital · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtypical response patterns have been a topic of increasing relevance since the advent of immune checkpoint inhibitors (ICIs), challenging the traditional RECIST (Response Evaluation Criteria in Solid Tumors) method of tumor response assessment. Newer immune-related response criteria can allow for the evolution of radiologic pseudoprogression, but still fail to capture the full range of atypical response patterns encountered in clinical reporting.

methodsWe did a detailed lesion-by-lesion analysis of the serial imaging of 46 renal cell carcinoma (RCC) patients treated with ICIs with the aim of capturing the full range of radiologic behaviour.

resultsAtypical response patterns observed included pseudoprogression (

conclusionsThere is a high incidence of atypical response patterns in RCC patients receiving ICIs and the study contributes to the growing literature on the abscopal effect. The recognition of these interesting and overlapping radiologic patterns challenges the oncologist to tweak treatment options such that the clinical benefits of ICIs are potentially maximized.

Indexed as

abscopal responseatypical response patternsdissociated responsepseudoprogressionrenal cell carcinomastereotactic body radiation therapy

Identifiers

PMID33918397
PMCPMC8038243
OpenAlexW3143183352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.